The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: GAMT vs GATM
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • Despite there being a valid 'cspec' property in the messages there's a discrepancy in message contents and CSPEC data: * Message Gene: GAMT CSPEC Genes: [ 'GATM' ] * Message MONDOs: MONDO:0012999 CSPEC MONDO: [ 'MONDO:0012996' ]
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000156.6:c.595dup

CA2579753928

2570639 (ClinVar)

Gene: GAMT (HGNC:2593)
Condition: guanidinoacetate methyltransferase deficiency (MONDO:0012999)
Inheritance Mode: Autosomal recessive inheritance
UUID: 700cbe30-d33b-4aa5-9cd1-05806d9e00c9
Approved on: 2025-10-07
Published on: 2025-10-07

HGVS expressions

NM_000156.6:c.595dup
NC_000019.10:g.1397476dup
CM000681.2:g.1397476dup
NC_000019.9:g.1397475dup
CM000681.1:g.1397475dup
NC_000019.8:g.1348475dup
NG_008283.1:g.18593dup
NG_009785.1:g.9079dup
ENST00000252288.8:c.595dup
ENST00000640164.1:n.428dup
ENST00000640762.1:c.526dup
ENST00000252288.6:c.595dup
NM_000156.5:c.595dup
More

Likely Pathogenic

Met criteria codes 4
PM2_Supporting PP4_Moderate PVS1_Moderate PM3_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Cerebral Creatine Deficiency Syndromes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GATM Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cerebral Creatine Deficiency Syndromes VCEP
The NM_000156.6:595dupG (p.Glu199GlyfsTer68) variant in GAMT is a frameshift variant predicted to cause a premature stop codon in the last exon of the gene and therefore to escape nonsense mediated decay. Less than 10% of the protein is predicted to be removed (PVS1_Moderate). This variant has been detected in one individual with an absent creatine peak on brain MRS and low plasma creatine (PMID: 32606525) (PP4_Moderate). This individual was homozygous for the variant (PMID: 32606525) (0.5pts, PM3_Supporting). This individual had an absent creatine peak on brain MRS (PMID: 32606525) (PP4_Moderate). This variant is absent in gnomAD v4.1.0. (PM2_Supporting). There is a ClinVar entry for this variant (Variation ID: 2570639). In summary, this variant meets the criteria to be classified as likely pathogenic for GAMT deficiency based on the GAMT-specific ACMG/AMP criteria applied, as specified by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel (Specifications Version 2.0.0): PVS1_Moderate, PM2_Supporting, PM3_Supporting, PP4_Moderate. (Classification approved by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel on October 7, 2025)
Met criteria codes
PM2_Supporting
This variant is absent in gnomAD v4.1.0. (PM2_Supporting).
PP4_Moderate
This individual had an absent creatine peak on brain MRS and low plasma creatine; no plasma or urine GAA level available (PMID: 32606525) (PP4_Moderate).
PVS1_Moderate
The NM_000156.6:595dupG (p.Glu199GlyfsTer68) variant in GAMT is a frameshift variant predicted to cause a premature stop codon in the last exon of the gene and therefore to escape nonsense mediated decay. Less than 10% of the protein is predicted to be removed. (PVS1_Moderate).
PM3_Supporting
This variant has been detected in one individual with GAMT deficiency (PMID: 32606525). This individual was homozygous for the variant (PMID: 32606525) (0.5pts, PM3_Supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.